Related Experiment Video
Updated: Jun 17, 2026

Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
Long-term stability of serum sodium in hemodialysis patients
Aldo J Peixoto1, Nayan Gowda, Chirag R Parikh
1Medical Service, VA Connecticut Healthcare System, West Haven, CT 06516, USA. aldo.peixoto@yale.edu
Insights
Serum sodium levels in hemodialysis (HD) patients are stable over time. This stability suggests pre-dialysis serum sodium can help personalize dialysate sodium prescriptions for better patient management.
Area of Science:
- Nephrology
- Clinical Chemistry
- Internal Medicine
Background:
- Hemodialysis (HD) patients exhibit a relationship between dialysate-to-plasma sodium gradient, blood pressure, and interdialytic weight gain.
- Understanding long-term serum sodium variability is crucial for managing HD patients.
Purpose of the Study:
- To determine the long-term variability of serum sodium levels in patients undergoing chronic hemodialysis.
- To assess the stability of serum sodium over a 12-month period in a stable HD cohort.
Main Methods:
- Retrospective cohort analysis of 100 stable chronic HD patients over 12 months.
- Evaluation of serum sodium and other routine analytes.
- Calculation of intraindividual coefficients of variation for serum sodium.
Main Results:
- Intraindividual coefficients of variation for serum sodium were low (pre-HD: 1.6%, post-HD: 1.8%).
- Overall serum sodium variability was comparable to laboratory assay variability and lower than other analytes (3.1-30.8%).
- Pre-dialysis serum sodium showed a trend toward hyponatremia (mean 136 ± 0.8 mEq/L).
Conclusions:
- Serum sodium levels demonstrate stability over time in hemodialysis patients.
- Pre-dialysis serum sodium can be a valuable parameter for tailoring individual dialysate sodium prescriptions.
Background:
A direct relationship between dialysate-to-plasma sodium gradient, blood pressure and interdialytic weight gain exists in hemodialysis (HD) patients. The aim of this study was to delineate the long-term variability of serum sodium in HD patients.
Methods:
We performed a retrospective cohort analysis of serum sodium and other analytes routinely evaluated in 100 stable chronic HD patients observed for 12 months.
Results:
Individual levels across the cohort varied from 122 to 145 m M , but 12-month intraindividual coefficients of variation for sodium were low (pre-HD = 1.6%; post-HD = 1.8%) with overall variability similar to that related to laboratory assay variability especially when compared with other analytes (3.1-30.8%). Pre-HD serum sodium had a trend toward hyponatremia (mean 136 +/- 0.8 m M ).
Conclusion:
Serum sodium is stable over time in HD patients. Pre-HD serum sodium may be used as a parameter for individualizing dialysate sodium prescription.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Regulation of Sodium and Potassium
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Serum Studies: Renal Function Tests
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis I: Introduction
